Xtant Medical Holdings, Inc.
XTNT · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $59 | $135 | $62 | $48 |
| - Cash | $6 | $6 | $20 | $18 |
| + Debt | $35 | $24 | $17 | $17 |
| Enterprise Value | $88 | $152 | $59 | $46 |
| Revenue | $117 | $91 | $58 | $55 |
| % Growth | 28.4% | 57.5% | 4.9% | – |
| Gross Profit | $68 | $55 | $32 | $32 |
| % Margin | 58.2% | 60.8% | 55.4% | 58.8% |
| EBITDA | -$8 | $5 | -$5 | -$3 |
| % Margin | -6.7% | 5.6% | -9.4% | -4.5% |
| Net Income | -$16 | $1 | -$8 | -$5 |
| % Margin | -14% | 0.7% | -14.6% | -8.8% |
| EPS Diluted | -0.12 | 0.005 | -0.09 | -0.057 |
| % Growth | -2,407.7% | 105.8% | -59.1% | – |
| Operating Cash Flow | -$12 | -$10 | -$5 | $0 |
| Capital Expenditures | -$4 | -$1 | -$2 | -$2 |
| Free Cash Flow | -$16 | -$11 | -$7 | -$2 |